These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20059335)

  • 1. H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.
    Sambhara S; Poland GA
    Annu Rev Med; 2010; 61():187-98. PubMed ID: 20059335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical vaccine development for H5N1 influenza.
    Clegg CH; Rininger JA; Baldwin SL
    Expert Rev Vaccines; 2013 Jul; 12(7):767-77. PubMed ID: 23885822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.
    Pandey A; Singh N; Sambhara S; Mittal SK
    Hum Vaccin; 2010 Feb; 6(2):178-88. PubMed ID: 19875936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral strategies for epidemic and pandemic preparedness.
    Jochmans D; Laporte M; Neyts J
    Cell Host Microbe; 2023 Jun; 31(6):856-860. PubMed ID: 37321170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on strategies for prevention and control of seasonal and pandemic influenza.
    Santibañez S; Fiore AE; Merlin TL; Redd S
    Am J Public Health; 2009 Oct; 99 Suppl 2(Suppl 2):S216-24. PubMed ID: 19797735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avian flu (H5N1): its epidemiology, prevention, and implications for anesthesiology.
    Edler AA
    J Clin Anesth; 2006 Feb; 18(1):1-4. PubMed ID: 16517323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting the challenge of influenza pandemic preparedness in developing countries.
    Fedson DS
    Emerg Infect Dis; 2009 Mar; 15(3):365-71. PubMed ID: 19239746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries.
    Apisarnthanarak A; Warren DK; Fraser VJ
    Clin Infect Dis; 2007 Nov; 45(10):1338-42. PubMed ID: 17968831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK preparedness for pandemic influenza.
    Coker R
    BMJ; 2007 May; 334(7601):965-6. PubMed ID: 17493986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vaccine allocation for the early mitigation of pandemic influenza.
    Matrajt L; Halloran ME; Longini IM
    PLoS Comput Biol; 2013; 9(3):e1002964. PubMed ID: 23555207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinician-initiated research on treating the host response to pandemic influenza.
    Fedson DS
    Hum Vaccin Immunother; 2018 Mar; 14(3):790-795. PubMed ID: 29058516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
    Prasad PV; Steele MK; Reed C; Meyers LA; Du Z; Pasco R; Alfaro-Murillo JA; Lewis B; Venkatramanan S; Schlitt J; Chen J; Orr M; Wilson ML; Eubank S; Wang L; Chinazzi M; Pastore Y Piontti A; Davis JT; Halloran ME; Longini I; Vespignani A; Pei S; Galanti M; Kandula S; Shaman J; Haw DJ; Arinaminpathy N; Biggerstaff M
    Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2300590120. PubMed ID: 37399393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a New Viral Vaccine Vector in Mice and Rhesus Macaques: J Paramyxovirus Expressing Hemagglutinin of Influenza A Virus H5N1.
    Abraham M; Beavis AC; Xiao P; Villinger FJ; Li Z; Jones CA; Tompkins SM; He B
    J Virol; 2021 Oct; 95(22):e0132121. PubMed ID: 34469242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
    Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
    J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine.
    Gou X; Wu X; Shi Y; Zhang K; Huang J
    Hum Vaccin Immunother; 2020; 16(2):286-294. PubMed ID: 31419167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.
    Hsieh CF; Chen YL; Lin CF; Ho JY; Huang CH; Chiu CH; Hsieh PW; Horng JT
    Sci Rep; 2016 Oct; 6():36015. PubMed ID: 27796330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-I ligand enhances the immunogenicity of recombinant H7HA protein.
    Cao W; Liepkalns JS; Kamal RP; Reber AJ; Kim JH; Hofstetter AR; Amoah S; Stevens J; Ranjan P; Gangappa S; York IA; Sambhara S
    Cell Immunol; 2016; 304-305():55-8. PubMed ID: 27106062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses.
    Bao J; Marathe B; Govorkova EA; Zheng JJ
    Angew Chem Int Ed Engl; 2016 Mar; 55(10):3438-41. PubMed ID: 26833677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States.
    Biggerstaff M; Reed C; Swerdlow DL; Gambhir M; Graitcer S; Finelli L; Borse RH; Rasmussen SA; Meltzer MI; Bridges CB
    Clin Infect Dis; 2015 May; 60 Suppl 1(Suppl 1):S20-9. PubMed ID: 25878298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bird to human transmission biases and vaccine escape mutants in H5N1 infections.
    Wagh K; Bhatia A; Greenbaum BD; Bhanot G
    PLoS One; 2014; 9(7):e100754. PubMed ID: 24988306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.